Meet Slotegrator at SBC Summit Barcelona 2023

During this year, Slotegrator has presented its solutions at the world’s largest events and venues.
Now it’s Barcelona’s turn, where one of the most anticipated events of this fall – SBC Summit
Barcelona 2023.

Slotegrator will present its new AI-powered capabilities of the turnkey online casino platform and
its unique mobile solution – Telegram casino – from the 19th to the 21st of September in the
Catalan capital.

The SBC Summit Barcelona is a must-attend event in the calendar where global leaders in
sports betting and iGaming assemble to discuss the future of the industry, exchange knowledge
and build powerful connections. It’s the best opportunity for the industry to explore the most-
anticipated product releases that feature 350+ world-class operators, suppliers, affiliates, media
and start-ups.

Slotegrator is preparing an interactive presentation to demonstrate the following features:
● The business intelligence (BI) module, which helps operators track the analytical data
they need to make strategic decisions, has become an Artificial BI module. Now it allows
operators to compare indicators and profitability of their project with others that operate in
the same market (withdrawal, average deposit sum, etc).
● Well-known modules like Casino Builder (for creating an individual site interface), Fraud
Detection (for collecting Big Data to reduce different types of risks), and KYC (responsible
for fast, smooth and consistent user verification) – now have improved functionality and
● ChatGPT integration, which can consult operators on how to increase income in their
project, among other issues.
● A multiplayer chat, a novel function that players can open on any of the online front pages
of the casino and communicate with other players. This effective retention tool creates an
opportunity for networking and creating player communities.
● The smoothless switch in payment and interchangeability – how auto-replacement
switches to another payment method when one is dropped.

Comments are closed.